Published in Neurotherapeutics on July 01, 2015
Induced pluripotent stem cells for modeling neurological disorders. World J Transplant (2015) 0.79
A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric Research. Stem Cells Int (2015) 0.75
Therapeutic Advances in Autism and Other Neurodevelopmental Disorders. Neurotherapeutics (2015) 0.75
Complexities of X chromosome inactivation status in female human induced pluripotent stem cells-a brief review and scientific update for autism research. J Neurodev Disord (2016) 0.75
Altered neurite morphology and cholinergic function of induced pluripotent stem cell-derived neurons from a patient with Kleefstra syndrome and autism. Transl Psychiatry (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
A TALE nuclease architecture for efficient genome editing. Nat Biotechnol (2010) 26.47
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell (1991) 17.00
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet (2008) 15.51
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature (2012) 14.76
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science (2008) 14.26
Alzheimer's disease: the amyloid cascade hypothesis. Science (1992) 13.80
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science (1997) 11.48
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet (2006) 11.14
MeCP2, a key contributor to neurological disease, activates and represses transcription. Science (2008) 10.11
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet (2001) 9.82
Neuroligins and neurexins link synaptic function to cognitive disease. Nature (2008) 9.23
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 9.23
Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med (2010) 9.19
Genome-wide association study identifies five new schizophrenia loci. Nat Genet (2011) 9.07
Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry (1987) 8.81
Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav (2003) 8.48
The story of Rett syndrome: from clinic to neurobiology. Neuron (2007) 8.08
Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol (1999) 7.69
A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell (2010) 7.51
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell (2004) 7.45
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Modelling schizophrenia using human induced pluripotent stem cells. Nature (2011) 7.41
Reversal of neurological defects in a mouse model of Rett syndrome. Science (2007) 7.09
Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron (2006) 6.50
Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron (2008) 6.26
Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science (2012) 6.21
UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet (1997) 5.97
The contribution of de novo coding mutations to autism spectrum disorder. Nature (2014) 5.94
Animal models of neuropsychiatric disorders. Nat Neurosci (2010) 5.78
Postnatal neurodevelopmental disorders: meeting at the synapse? Science (2003) 5.71
Modelling the long QT syndrome with induced pluripotent stem cells. Nature (2011) 5.68
Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature (2012) 5.47
Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell (2010) 5.43
Severe impairments of social interaction and associated abnormalities in children: epidemiology and classification. J Autism Dev Disord (1979) 5.40
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature (2009) 5.37
Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30
Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet (2011) 4.67
Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron (1999) 4.59
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature (2010) 4.38
Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med (2012) 4.36
The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry (1999) 4.26
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci (2006) 4.22
Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed) (1987) 4.02
Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature (2012) 3.83
Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med (2011) 3.66
The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J Dev Behav Pediatr (2001) 3.64
Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci (2009) 3.42
Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet (2003) 3.25
L1 retrotransposition in neurons is modulated by MeCP2. Nature (2010) 3.25
Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet (1989) 3.22
A role for glia in the progression of Rett's syndrome. Nature (2011) 3.18
Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors. Nat Neurosci (2007) 3.13
Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci (2010) 3.00
Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell (2007) 2.87
Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor. Nature (2005) 2.78
Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One (2011) 2.74
Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet (2012) 2.65
Autism: many genes, common pathways? Cell (2008) 2.63
Genetics of autism spectrum disorders. Trends Cogn Sci (2011) 2.61
The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci (2011) 2.61
A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet (2003) 2.51
Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry (2002) 2.51
Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet (2013) 2.47
Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol (2013) 2.41
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet (2011) 2.38
Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci (2009) 2.35
Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med (2005) 2.04
Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci (2010) 1.98
Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet (2008) 1.97
A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Sci Transl Med (2012) 1.95
The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome). Mol Syndromol (2011) 1.94
SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature (2013) 1.93
Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry (2012) 1.91
Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet (2011) 1.87
Animal models of restricted repetitive behavior in autism. Behav Brain Res (2006) 1.78
Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc Natl Acad Sci U S A (2010) 1.78
Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One (2011) 1.75
A big-world network in ASD: dynamical connectivity analysis reflects a deficit in long-range connections and an excess of short-range connections. Neuropsychologia (2010) 1.73
Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nat Neurosci (2013) 1.68
Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. J Neurosci (2000) 1.68
A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation. Proc Natl Acad Sci U S A (2005) 1.65
Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc Natl Acad Sci U S A (2011) 1.63
Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice. J Neurosci (2010) 1.52
Diseases in a dish: modeling human genetic disorders using induced pluripotent cells. Nat Med (2011) 1.50
The genetics of neurodevelopmental disease. Curr Opin Neurobiol (2010) 1.49
Post-mortem clinical pharmacology. Br J Clin Pharmacol (2008) 1.48
Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology (2000) 1.48
Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models. Schizophr Bull (2009) 1.44
Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J Neuropathol Exp Neurol (1998) 1.41
Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises. Hum Mol Genet (2011) 1.37
Medicine. iPSC disease modeling. Science (2012) 1.36
Trisomy correction in Down syndrome induced pluripotent stem cells. Cell Stem Cell (2012) 1.35
Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun (2012) 1.33
Autophagy in stem cell maintenance and differentiation. Stem Cells Dev (2012) 1.15
Modeling neurodevelopmental disorders using human neurons. Curr Opin Neurobiol (2012) 0.94
Evidence for premature aging due to oxidative stress in iPSCs from Cockayne syndrome. Hum Mol Genet (2012) 0.94
A quantitative proteomic and transcriptomic comparison of human mesenchymal stem cells from bone marrow and umbilical cord vein. Proteomics (2012) 0.88
Skeletal muscle cells expressing VEGF induce capillary formation and reduce cardiac injury in rats. Int J Cardiol (2006) 0.85
Treadmill exercise induces age-related changes in aversive memory, neuroinflammatory and epigenetic processes in the rat hippocampus. Neurobiol Learn Mem (2013) 0.84
Exercise induces age-dependent changes on epigenetic parameters in rat hippocampus: a preliminary study. Exp Gerontol (2012) 0.78
Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus. Cancer Gene Ther (2005) 0.75